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for early breast cancer includes a wide local excision with 
adjuvant radiotherapy. Clinical data suggest, that 
perturbations induced by surgery and the subsequent wound 
fluids, which are rich in cytokines and growth factors, may 
stimulate residual disease. Numerous studies demonstrate, 
that 90% of the local recurrence after surgery occur in the 
same quadrant as the primary cancer. It has been proposed, 
that cancer cells displaying the stem-like phenotype play a 
critical role in local recurrence, invasion and metastasis. One 
of the new possibilities in conservative cancer treatment is 
intraoperative radiotherapy (IORT). IORT delivers high dose 
of radiation as one single fraction at the time of surgery. It 
was previously reported, that IORT alters the 
microenvironment through the modulation of wound healing 
response. Thus we wondered, whether wound fluids can 
induce the enrichment of breast cancer stem cells 
phenotype in breast cancer cell lines and whether IORT 
plays inhibitory role in this process. 
 
Material and Methods: Wound fluids form patients which 
underwent IORT (IR-WF), as well as control group without 
radiotherapy treatment (WF), were collected week after the 
surgery. Three human cancer cell lines with different 
molecular status (basal – MDA-MB-468, luminal – MCF7 and 
Her2-positive – BT-474) were then incubated with wound 
fluids (WF, IR-WF) in complete culture medium (10%). After 
four days of incubation the cancer stem-cell phenotype was 
established. 
 
Results: Flow cytometry and RT-qPCR analysis revealed, that 
wound fluids from patients who received IORT decreased the 
phenotype of cancer-stem cells in the basal (MDA-MB-468) 
and luminal subtype (MCF7) of cancer cell lines compared to 
IORT-untreated patients. Such changes were not confirmed in 
HER2-posive cell line (BT-474). 
 
Conclusion: The surgical wound fluids from both groups (WF 
and IR-WF) affect the putative stem cell phenotype. In IR-WF 
group, the lower stem cell phenotype was observed 
compared to fluids harvested after surgery alone.  
This work was supported by NSC grant no UMO-
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Purpose or Objective: To determine the influence of two 
different injection schedules on the pimonidazole hypoxic 
fraction (pHF) in three different head and neck human 
squamous cell carcinoma (HNSCC) xenograft tumour models. 
 
 
Material and Methods: Three different HNSCC cell lines 
(FaDu, UT-SCC-5, UT-SCC-14) grown as xenograft tumours in 
nude mice (5 per cell line) where examined with different 
pimonidazole injection schedules. Either one single injection 
60 minutes prior to tumour excision (100 mg/kg BW i.p.) or 
three injections (each 33 mg/kg BW i.p.) starting 180 minutes 
before tumour excision with 60 minutes interval between 
injections. Both groups where given the perfusion marker 
Hoechst 33342 i.v. 1 minute prior to tumour excision. 
Tumours were snap frozen and consecutive central cross-
sections (10µm) where stained with antibodies for 
pimonidazole and CD31. Using image analysis the pHF and 
other parameters of the microenvironment were determined. 
 
Results: No statistically significant differences in pHF nor in 
visual staining patterns were observed after single versus 
multiple injections of pimonidazole (table and figure 1). 
Table 1: Mean values of the pHF [SD] in %.  
 
 
 
 
 
Fig. 1: pHF for the cell lines for single and multiple 
pimonidazole injection (mean value for pHF of the two 
analysed sections per tumour, closed symbols for single, open 
for multiple injections) 
 
Conclusion: In the HNSCC xenograft models investigated here 
pimonidazole detects predominantly chronic hypoxia. 
Assessment of cycling hypoxia requires alternative methods. 
Our data suggest that cycling hypoxia occurs either at a low 
level in our models or that hypoxia cycles so rapid that 
pimonidazole cannot bind sufficiently or cycling hypoxia 
levels are not low enough for pimonidazole reduction. 
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Purpose or Objective: Radiotherapy toxicity is related to 
oxidative stress-mediated endothelial dysfunction. Here, we 
investigated on radioprotective properties of Vitamin D 
(Vit.D) on human endothelial cells (HUVEC). 
 
Material and Methods: HUVEC, pre-treated with Vit.D, were 
exposed to ionizing radiation (IR): ROS production, cellular 
viability, apoptosis, senescence and western blot for protein 
detection were performed. The role of MAPKs pathway was 
investigated by using U0126 (10 μM) MEKs/ERKs-, SB203580 
(2.5 μM) p38-inhibitor or by over/expressing MKK6 p38-
upstream activator. 
 
Results: Vit.D reduced IR-induced ROS production protecting 
proliferating and quiescent HUVEC from cellular apoptosis or 
senescence, respectively, by regulating MAPKs pathways. In 
proliferating HUVEC, Vit.D prevented IR-induced apoptosis by 
activating ERKs while in quiescent HUVEC counteracted IR-
induced senescence by inhibiting the p38-IR-induced 
activation. MEKs&ERKs inhibition in proliferating or 
MKK6/mediated p38 activation in quiescent HUVEC, 
